The document is a thesis submitted by Dawn V Tomy for the degree of Master of Pharmacy in Pharmacology. It discusses conducting a study on the plant Croton laevigatus Vahl. The objectives are to determine the phytochemicals, toxicity, cytotoxic and antitumor activities, and antioxidant and anti-inflammatory properties of C. laevigatus. The plan of work involves extraction of the plant leaves, phytochemical analysis, subacute toxicity studies, and evaluation of cytotoxicity, antioxidant activities and other pharmacological properties.
PRECLINICAL SCREENING MODELS
In vitro methods
• Patch clamp technique in kidney cells
• Perfusion of isolated kidney tubules
• Isolated perfused kidney
In vivo methods
• Diuretic activity in rats (LIPSCHITZ test)
• Saluretic activity in rats
• Diuretic and saluretic activity in dogs
• Clearance methods
• Micro puncture techniques in the rat
• Stop-flow technique
PRECLINICAL SCREENING MODELS
In vitro methods
• Patch clamp technique in kidney cells
• Perfusion of isolated kidney tubules
• Isolated perfused kidney
In vivo methods
• Diuretic activity in rats (LIPSCHITZ test)
• Saluretic activity in rats
• Diuretic and saluretic activity in dogs
• Clearance methods
• Micro puncture techniques in the rat
• Stop-flow technique
Introduction to Screening Models of Hepatoprotective Drugs
Liver toxicity, Drugs causing DILI, Markers of hepatotoxicity
List of hepatoprotectives, Functions of liver
Screening models of hepatoprotective drugs
Presented by
I. Sai Reddemma
Department of Pharmacology
Introduction to Screening Models Of Anti Cancer Drugs
Need for novel anti cancer drugs, In - vitro methods, In - vivo methods, Advantages and disadvantages
Presented by
T. Niranjan Reddy
Department of Pharmacology
Pharmacological screening of Anti-psychotic agentsAbin Joy
Presentation contents are:
Introduction, Definition of psychosis, Classification of anti-psychotics, MOA of anti-psychotic agents and screening models.
Introduction to Screening Models of Hepatoprotective Drugs
Liver toxicity, Drugs causing DILI, Markers of hepatotoxicity
List of hepatoprotectives, Functions of liver
Screening models of hepatoprotective drugs
Presented by
I. Sai Reddemma
Department of Pharmacology
Introduction to Screening Models Of Anti Cancer Drugs
Need for novel anti cancer drugs, In - vitro methods, In - vivo methods, Advantages and disadvantages
Presented by
T. Niranjan Reddy
Department of Pharmacology
Pharmacological screening of Anti-psychotic agentsAbin Joy
Presentation contents are:
Introduction, Definition of psychosis, Classification of anti-psychotics, MOA of anti-psychotic agents and screening models.
การวิเคราะห์ฤทธิ์ต้านอนุมูลอิสระที่ระยะต่างกันในกล้วยเล็บมือนาง
Analysis of Antioxidant Activity at Different Stage in Musa (AA group) ‘Kluai Leb Mu Nang’
อดิศร จำรูญ
This is an Engg Biotechnology project based on medicinal plant i.e singapore cherry or jamaican cherry tree (scientific name Muntingia calabure ), we did in 2013 in GMIT college Davangere, karanataka, India. i have complete project detail what we did..,
International Journal of Pharmaceutical Science Invention (IJPSI) is an international journal intended for professionals and researchers in all fields of Pahrmaceutical Science. IJPSI publishes research articles and reviews within the whole field Pharmacy and Pharmaceutical Science, new teaching methods, assessment, validation and the impact of new technologies and it will continue to provide information on the latest trends and developments in this ever-expanding subject. The publications of papers are selected through double peer reviewed to ensure originality, relevance, and readability. The articles published in our journal can be accessed online.
Anti-diabetic potentials of Sorbaria tomentosa Lindl. Rehder: Phytochemistry ...RaktimavaDasSarkar
Original Artcle by Falak Naz, Muhammad Zahoor, Muhammad Ayaz, Muhammad Ashraf, Asif Nawaz, Amal Alotaibi.
Presentation prepared by Raktimava Das Sarkar
ABSTRACT
Overactive bladder (OAB) is a prevalent condition which has an adverse effect on quality of life. The presence
of urgency incontinence confers significant morbidity above and beyond that of OAB sufferers who are
continent. The primary treatment for OAB and urgency incontinence is a combination of behavioral measures
and antimuscarinic drug therapy. The ideal antimuscarinic agent should effectively relieve the symptoms of
OAB, with the minimum of side effects; it should be available as a once-daily sustained release formulation
and in dosage strength that allows easy dose titration for the majority of sufferers. Solifenacin succinate was
launched in 2005 and has been shown in both short and long term clinical trials to fulfill these requirements.
Solifenacin is a competitive M3 receptor antagonist with a long half-life (45-68 hours). It is available in two
dosage strengths namely a 5 or 10 mg once-daily tablet. The efficacy and tolerability of solifenacin for the
treatment of all symptoms of OAB has been evaluated in a number of large, placebo controlled, randomized
trials. Long-term safety, efficacy, tolerability and persistence with treatment have been established in an open
label 40 week continuation study.
KEYWORDS
Solifenacin, Urinary incontinence, Overactive bladder and Wet granulation method.
ABSTRACT- The anticancer drug arsenic trioxide is effective for acute promyelocytic leukemia. But the clinical trials are
restricted due to its potential side effects. Since the major part of arsenic metabolism and detoxification occurs in liver,
this organ faces the major threat. The hepatic side effects include fatty liver, fibrosis, and inflammation and hepatocyte
degeneration. Our study aimed to evaluate the protective potential of the fatty acid, docosahexaenoic acid, against adversities
of arsenic trioxide in an in vitro model, the Chang liver cells. Two preliminary dose standardization assays, cell
viability and lactate dehydrogenase release assays, were employed. The assays were performed as Pre-treatment,
Co-treatment and Post treatment experiments for a period of 24 hours. Arsenic trioxide at various doses (2.5, 5, 7.5, 10,
12.5 and 15 μM) showed a significant (p≤0.05) dose dependant reduction in cell viability along with a dose dependant
enhancement of lactate dehydrogenase release. However when the cells were treated with a combination of docosahexaenoic
acid at varying concentrations (50, 75, 100, 125 and 150 μM), the above mentioned conditions were found to be
reversed in Pre-treatment and Co-treatment experiments, but not in Post treatment. The most effective combination was
found to be 10 μM arsenic trioxide with 100 μM of docosahexaenoic acid in both Pre-treatment and Co- treatment studies.
Thus the preliminary assays of our study showed that docosahexaenoic acid administration as Pre-treatment or
Co-treatment can aid in reducing arsenic trioxide induced hepatotoxicity. Further studies are required to elucidate the mechanisms
behind the protective effects.
Key Words– Arsenic trioxide, hepatotoxicity, docosahexaenoic acid, cell damage
Alternative to animal toxicit testing.pptxANANYAPANDEY71
Alternative to animal toxicity studies
pharmacological and toxicological studies
hetcam test
pyrogen test
3R
Refinment,Reduction &Replacement
In-Silico methods
CADD, QSAR
ABSTRACT- Medicinal plants contain valuable sources of biological components that are helpful in control and cure of
ageing diseases. Protein component present in various parts of the medicinal plants is the rich sources of medicine that
contains a permanent cure for several diseases. The studies on edible sources like C. lanatus testa (or seed coat) are to be
conducted to understand, the better action against human diseases. The purified inhibitor is separated by SDS PAGE and
analyzed by MS-MASCOT shown sequence as “MQDVKTYPPAAPVPATPRFGSLAG SLIEINR”. The C. lanatus testa
crude extracts were revealed good antifungal activity against A. niger (18mm) and C. albicans (13mm). The C. lanatus
testa purified extracts were revealed good antifungal activity against A. niger (21 mm) and C. albicans (20mm).
Fluconazole was used as a fungal standard, shown inhibition zone for A. niger (14mm) and C. albicans (20mm). The C.
lanatus Trypsin Inhibitor (CLTI) extracts from testa at 100μg/ml were shown good activity with A. niger acting as
antifungal agent compared to standard antibiotic (Fluconazole). The C. lanatus testa Trypsin inhibitor, it is also shown
good results for anti-proliferative activity. The results were shown good antiproliferation activity with MCF-7 (Breast
Cancer) cell line due to gradual decrease in the percentage of cell survival. The IC50 for standard drug (Tamoxifen) with
MCF-7 (Breast Cancer) cell line was shown as 12μg/ml. The IC50 of CLTI peptide was shown as 60μg/ml and crude as
190μg/ml. The IC50 for standard drug (Tamoxifen) with Hep-G2 (Liver Cancer) Cell line is shown as11 μg/ml. The IC50 of
CLTI peptide with Hep-G2 (Liver Cancer) Cell line was shown as 41 μg/ml and C. lanatus testa crude extract as 144
μg/ml. The experimentation concludes that serine protease inhibitors present in testa of C.lanatus shown both antifungal
and antiproliferative properties.
Key Words- C. lanatus testa, Trypsin inhibitor, Antifungal activity, Antiproliferative activity, Breast and liver cell lines
Spectrophotometric Estimation of Rosuvastatin Calcium in Bulk and Pharmaceuti...SriramNagarajan15
Rosuvastatin calcium of the class statins is used for primary hyperlipidemias. It is a selective and competitive inhibitor of HMG-CoA reductase. In the present work, simple, sensitive and economic spectrophotometric method has been developed for quantitative determination of Rosuvastatin calcium. In the present spectrophotometric method Rosuvastatin calcium was dissolved in double distilled water. It exhibited an absorption maximum at 241 nm and obeyed Beer’s law in the concentration range of 5-25g/ml. The results of analysis have been validated and found to be sensitive, precise and accurate for quantitative determination of Rosuvastatin calcium in bulk drug and pharmaceutical formulations.
Phytochemical Screening and Evaluation of Cytotoxicity and Thrombolytic Prope...IOSR Journals
The rural and marginal people of Bangladesh are deprived of modern treatment facilities and hence greatly depend on medicinal plants. Besides, the higher cost and toxicity of synthetic drugs drives scientists towards search for natural source of medication for a number of diseases. Cost-effectiveness, easy availability and fewer side effects are making the herbal medicine more popular both among rural and city people. Plants with Cytotoxic and clot lysis potential are good candidate as source of novel anti-tumor agents and thrombolytic drugs. This study aimed at screening out of phytochemical constituents and evaluation of cytotoxicity and thrombolytic potential of an important medicinal plant Achyranthes aspera methanolic leaf extract. In vitro phytochemical screening of A. aspera leaf extract carried out by qualitative tests revealed the presence of alkaloids, glycosides, cardiac glycosides, flavonoids, tannins, terpenoids, steroids and saponins while phlobatannins were absent. Cytotoxicity test of A. aspera leaf extract carried out by Brine shrimp Lethality (BSL) Bioassay showed the highest percentage of mortality (90%) in 1250 μg/ml and LC50 value was 50.12 μg/ml. Thrombolytic test showed 32.87 ± 9.42% clot lytic activity for A. aspera while positive control (streptokinase) and negative control (water) showed 81.19 ± 3.78% and 6.67 ± 2.58% clot lysis, respectively. Synergistic effect of streptokinase and A. aspera extract also produced better result (56.30 ± 6.95%) than A. aspera alone.
Similar to EVALUATION OF ANTI-OXIDANT AND ANTI-TUMOUR ACTIVITIES OF CROTON LAEVIGATUS Vahl. (20)
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
EVALUATION OF ANTI-OXIDANT AND ANTI-TUMOUR ACTIVITIES OF CROTON LAEVIGATUS Vahl.
1. BY
DAWN V TOMY, B.Pharm.,
Reg.No: 26106393
1
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
2. Thesis Submitted to
The Tamilnadu Dr. M.G.R Medical University, Chennai In partial
fulfillment of the requirements For the award of the Degree of
MASTER OF PHARMACY IN PHARMACOLOGY
Submitted by
DAWN. V .TOMY, B. Pharm.,
Reg.No: 26106393
Dept. of Pharmacology
RVS College of Pharmaceutical Sciences, Sulur, Coimbatore.
2
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
3. Under the guidance of
Institutional Guide Industrial Guide
• Mrs. C. Maheswari, • Dr. T. D Babu, Ph.D.,
M.Pharm, (Ph.D)., • Asst. Professor, Dept. of
• Lecturer, Dept. of Pharmacology, Biochemistry,
• RVS College of Pharmaceutical • Amala Cancer Research Centre,
Sciences, Sulur, Coimbatore - 641 • Amala Nagar, Thrissur, Kerala -
402. 680 555.
3
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
4. INTRODUCTION
The nature has provided mankind the greatest
gift, ‘Medicinal Plants’. They play an important role in the
preservation of our health by curing infectious and
degenerative diseases. The medicinal properties of the plants
are due to the presence of bioactive compounds, produced
as by-products of primary metabolism. These compounds
protect the plants from infections
microorganisms, pests, various climatic stress conditions and
other hazards in the environment. They also contribute to
the development of new drugs. Hence, it has always been of
great interest to the scientists working on various disease 4
conditions. PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE
RVS COLLEGE OF Friday, March 15, 2013
5. The systematic screening of the plant, C. laevigatus Vahl.
The plant has been reported to be used in the traditional
Chinese medicine. Roots and leaves of the plant were
usually used by the Dai people (China) as a traditional drug
for treating fractures, malaria, stomach ache and wounds
received from falling. Almost 29 compounds were isolated
from the methanol extract of its leaves. Cytotoxicity of
diterpenoids isolated from C. laevigatus were initially
investigated on HeLa cell line by applying MTT method and
found modest cytotoxicity against HeLa cells (Zou et
al., 2010). No other pharmacological research has been
reported on this plant.
5
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
6. LITERATURE REVIEW
The C. laevigatus Vahl. belonging to the family Euphorbiaceae is
distributed mainly in India and China in the provinces of
Yunnan, Guangdong, and Hainan.
They are usually shrubs or trees, up to 1-5 m tall. Found as dense or
open forests; below 100-600 m. Roots and leaves of the plant are
usually used by the Dai people as a traditional drug for treating
fractures, malaria, stomach ache and wounds received from falling.
The chemical constituents of C. laevigatus were systematically
investigated with 29 compounds isolated from the methanol extract
of its leaves.
Cytotoxicity of diterpenoids isolated from C. laevigatus were initially
investigated on HeLa cell line by applying MTT methods. 6
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
7. AIM AND OBJECTIVES
•Phytochemical determination of biologically
active compounds from C. laevigatus Vahl.
•Determination of sub-acute toxicity of
methanolic extract of C. laevigatus.
•Analysis of cytotoxicity and anti-tumour
activities of C. laevigatus.
•Evaluation of anti-oxidant and anti-
inflammatory properties of C. laevigatus.
7
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
8. PLAN OF WORK
Sub-acute toxicity studies
8
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
9. PLANT PROFILE
Botanical Name: Croton laevigatus Vahl.
Common Names: Koteputol, Pongalam,
Somaraaji, Thomarayam.
Scientific Classification:
Kingdom - Plantae
Subkingdom - Angiosperms
Super division - Magnoliophyta
Division - Magnoliopsida
Class - Eudicots
Sub class - Rosids
Order - Malpighiales
Family - Euphorbiaceae
Subfamily - Crotonideae
Genus - Croton
Species - laevigatus 9
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
10. MATERIALS AND METHODS
1. Collection of plant sample
The leaves of C. laevigatus Vahl.
was collected from the Thrissur district
of Kerala. The plant was identified by Dr.
P. Sujanapal, Taxonomist, Kerala Forest
Research Institute (KFRI), Peechi.
The sample was dried in shade and
powdered using mixer grinder. 10
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
11. 2. Preparation of extract
The powder was extracted
with methanol by maceration. The
extract was filtered through
Whatman #1 filter paper and the
filtrate was evaporated to
dryness, dissolved in Normal
Saline (NS) and used for biological
11
analysis.
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
12. 3. Phytochemical screening
Qualitative phytochemical
screening of plant extracts was
done
The extract of the plant was
subjected to chemical tests for the
identification of various active
constituents
12
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
13. 4. Determination of in vitro cytotoxicity
of leaves of C. laevigatus extracts (trypan blue
die exclusion method)
Tumour cell lines
•Daltons Lymphoma Ascites (DLA)
cells.
•Ehrlich Ascites tumour (EAC) cells.
•Jurkat cells.
% of cytotoxicity = Number of dead cells x 100
Number of total cells
13
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
14. 5. In vitro anti-oxidant activities
The anti-oxidant properties of
the plant extract was analyzed by
determining the scavenging effects
of free radicals such as
superoxide, hydroxyl and DPPH
radical with in vitro assay systems.
14
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
15. DPPH radical scavenging assay:
Principle
In its radical form, DPPH has an absorption band at 515 nm, which
disappear on its reduction. Scavenging of DPPH radical by anti-oxidant compounds will
decrease the colour intensity, which can be compared with the control to get the
percent inhibition.
Reagents
Methanol and freshly prepared DPPH stored in brown bottle
Procedure
Different concentrations of extract of C. laevigatus were added to 0.375 ml
of freshly prepared DPPH solution in methanol. The volume was made up to 2 ml with
methanol. After 20 minutes, the absorbance was measured at 515 nm. The
percentage inhibition was calculated and concentration needed for 50% inhibition was
found out.
% of inhibition = OD of control - OD of test X 100
OD of control
15
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
16. 5.2 Superoxide radical scavenging activity
Principle: The superoxide scavenging was determined by the Nitro Blue Tetrazolium
(NBT) reduction method, which depends on light induced super oxide radical generation
by riboflavin. The super oxide radical will reduce the NBT to a blue coloured formazan
complex, which is measurable at 560 nm.
Reagents: Phosphate buffer (0.06M, pH 7.8), EDTA (0.1M) containing 1.5 mg of sodium
cyanide per 100 ml, riboflavin (0.12 mM) stored cold in a dark bottle and NBT (1.5 mM)
stored cold.
Procedure: Different concentrations of extracts ranging from 100 to 1000 μg/ml were
added to the reaction mixture containing 3 μg NaCN in 0.1 M EDTA; NBT 50µg, 0.12 mM
riboflavin and 0.6 M phosphate buffer (pH 7.8) in a final volume of 3 ml. The tubes
containing the reaction mixture were continuously illuminated with incandescent lamp for
15 min. The Optical Density (OD) measurements were taken at 560 nm before and after
illumination. The effect of test material to inhibit superoxide generation was evaluated by
comparing the OD of control and treated samples.
% of inhibition = OD of control - OD of test X 100
OD of control
16
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
17. 5.3 Hydroxyl radical scavenging activity
Principle: Hydroxyl radical scavenging was measured by studying the competition between
deoxyribose and the test compounds for hydroxyl radicals generated from the
Fe3+/ascorbate/EDTA/H2O2 system (Fenton reaction). The hydroxyl radical attacks epoxy
ribose, which eventually results in Thiobarbituric Acid Reacting Substances (TBARS)
formation, which is estimated using a spectrophotometer at 530 nm.
Reagents: Hydroxyl buffer (pH 7.4), H2O2 (1 mM) prepared freshly and stored in a brown
bottle, EDTA (0.1 mM), FeCl3 (0.1 mM) prepared freshly and stored in brown bottle, Ascorbic
acid (0.1 mM) freshly prepared, deoxy ribose (2.8 mM).
Procedure: The reaction system contained deoxyribose (2.8 mM), EDTA (0.1 mM), FeCl3 (0.1
mM), KH2PO4 KOH buffer (20 mM; pH 7.4) and from 100 to 1000 μg/ml of the test material
in a final volume of 1 ml. The reaction mixture was incubated for 37o C for 1 hour and is
estimated using a spectrophotometer at 530 nm.. The scavenging activity of hydroxyl radicals
was expressed as
% of inhibition = OD of control – OD of test X 100
OD of control
17
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
18. 6. Acute toxicity study
Swiss albino mice were administered the extract of C.
laevigatus in doses of 500 and 1000 mg/kg by oral for 14 days
and the following parameters were determined to evaluate the
toxicity.
a) Mortality
b) Weight change
c) Food and water consumption
d) Hematological function
e) Liver Function
f) Renal Function
Adult Swiss albino mice of age approximately 6 to 8
weeks old with weights in the range of 25-30g were used for
experiment.
18
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
19. Parameters estimated
Liver Function Test (LFT) Method
1. Serum Gutamate Oxalo acetate Transaminase (SGOT) IFCC method
2. Serum Glutamate Pyruvate transaminase (SGPT) IFCC method
3. Alkaline phosphatase (ALP) PNPP hydrolysis Method/kinetic
4. Albumin BCG Dye Binding Method
5. Globulins Calculation
6. Total Protein Biuret method
7. Bilirubin Total Jendrassik-Diazotized Sulfanilic acid method
Renal Function Test (RFT)
1. Serum Urea Urease calorimetric kinetic method
2. Creatinine JAFFE-kinetic method
19
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
20. Hematological profile
Blood was analyzed to determine the variations in
hematological parameters like haemoglobin, RBC and
platelet using haematology analyzer (Model ABX-
Micro-S-60).
The total white blood cells (WBC) were measured
after diluting the blood in Turk’s fluid and counting them
using a haemocytometer under magnification by
microscope (10 X).
To measure the differential count, blood was
spread on a clean slide and stained with Leishman’s
stain. Various types of cells were counted using a
microscope under magnification (100 X). 20
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
21. 7. Anti-inflammatory activities
a) Carrageenan induced acute inflammation.
Increase in paw thickness was measured using Vernier caliper
before and after carrageenan injection and thereafter at
first, second, third, fourth, fifth and twenty-fourth hours. The
increase in thickness as a measure of inflammatory edema can be
calculated by using the formula, Pt - Po where Po is initial
thickness and Pt is thickness at time‘t’
b) Formalin induced chronic inflammation.
The increase in thickness as a measure of inflammatory
oedema can be calculated by using the formula, Pt - Po where
Po is initial thickness and Pt is thickness at time‘t’.
21
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
22. 8. Anti-tumour
a) Solid tumour: The tumour volume was
calculated using the formula V = 4/3 π r12 r2
where r1 is the minor radius and r2 is the major
radius.
b) Ascites tumour: The life span of animals
was calculated using the formula:
% Increase in life span (ILS) = (T-
C)/C 100, where T and C are mean survival of
treated and control mice. 22
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
23. Statistical analysis
The values are presented as mean SD.
Differences between group’s means were
estimated using a one way analysis of
variance followed by Tukey test, using
Graph Pad In stat Software. The results
were considered statistically significant when
P<0.05.
23
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
24. RESULTS
1. Phytochemical screening
The phytochemical screening of the C. laevigatus Vahl.
methanol extract showed the presence of alkaloids, carbohydrates,
proteins, steroids, glycosides and polyphenols (Tab. 1).
Table1: Results of the phytochemical screening
“+”Present” Phytochemicals Methanol extract “-“Absent
Alkaloids +
Carbohydrates +
Proteins +
Amino acids -
Steroids +
Glycosides +
Saponnins -
Polyphenols + 24
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
25. 2. In vitro cytotoxicity
The C. laevigatus methanol extract showed marked cytotoxicity
activity against DLA, EAC and Jurkat cell lines. The concentration
required for 50% death (IC50) was found to be 37, 52 and 87µg/ml
respectively.
100
90
80
% of inhibition
70
60
50
40 IC50 = 37μg/ml
30
20
10
0
0 25 50 75 100 125 150
Concentration Of Drug In µg/ml
Figure 2: Cytotoxicity effect of C. laevigatus against DLA cell lines. 25
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
26. 100
90
80
70
60
50
% of inhibition
40 IC50 = 52μg/ml
30
20
10
0
0 25 50 75 100 125 150
Concentration Of Drug In µg/ml
Figure 3: Cytotoxicity effect of C. laevigatus against EAC cell lines.
26
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
27. 100
90
80
70
60
% of inhibition
50 IC50 = 87μg/ml
40
30
20
10
0
0 25 50 75 100 125 150
Concentration Of Drug In µg/ml
Figure 4: Cytotoxicity effect of C. laevigatus against Jurkat cell lines. 27
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
28. 3. In vitro anti-oxidant activities
In vitro anti-oxidant activities of C. laevigatus methanol extract was evaluated
using DPPH, superoxide and hydroxyl radical scavenging assays. The results were
expressed in IC50 values.
3.1 DPPH radical scavenging activity
The reduction capability was determined by reduction in the absorbance at 515
nm. The stable free radical DPPH was effectively scavenged by C. laevigatus methanol
extract with IC50 value 130 μg/ml.
100
90
80
70
% of inhibition
60
50
40
30 IC50 = 130μg/ml
20
10
0
0 100 200 300 400 500 600 700 800 900 1000
28
Concentration of drug (µg/ml)
Figure 5: Effect of C. laevigatus crude extract in inhibiting DPPH radical.
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
29. 3.2 Superoxide radical scavenging activity
The C. laevigatus methanol extract have significant scavenging of
superoxide radicals. The amount of extract needed for 50% inhibition was
found to be 110 μg/ml.
100
90
80
70
60
% of inhibition
50
40
30 IC50 = 110μg/ml
20
10
0
0 100 200 300 400 500 600 700 800 900 1000 1100
Concentration of drug (µg/ml)
Figure 6: Effect of C. laevigatus crude extract in inhibiting superoxide radical scavenging 29
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
30. 3.3 Hydroxyl radical scavenging activity
The concentration of the extract needed for 50% (IC50) inhibition of hydroxyl
radical was found to be 890 μg/ml.
100
90
80
70
60
50
% of inhibition
40
30
IC50 = 890μg/ml
20
10
0
0 100 200 300 400 500 600 700 800 900 1,000 1,100
Concentration of drug (µg/ml)
Figure 7: Effect of C. laevigatus crude extract in inhibiting hydroxyl radical scavenging. 30
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
31. 4. Acute toxicity study
Croton laevigatus methanol extract treatment caused no deaths in any
of the groups. Organ weight, food and water consumption, hemoglobin content and total
WBC count were found to be almost similar to that of control. Biochemical assays for liver
and kidney functions also revealed the safety of C. laevigatus methanol extract as an anti-
oxidant.
The administration of C. laevigatus methanolic extract did not produce
any mortality at doses of 500 and 1000 mg/kg of body weight for 14 days. This indicates
that the extract prepared from C. laevigatus, even at very high concentration was not lethal
to treated mice.
.
Table 2: Effect of C. laevigatus methanolic extract on mortality
Group Dose Mortality
(mg/kg of body weight)
C. laevigatus methanolic extract (500 mg/kg) 500 No
C. laevigatus methanolic extract (1000 mg/kg) 1000 No
31
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
32. Administration of extract at doses 500 and 1000mg/kg of body weight did not produce any
decrease in the body weight in Swiss Albino mice used in our study.
35
30
25
Body weight in grams
20
15
Normal
10 CL-500mg/kg
CL-750mg/kg
5
0
1 st 4 th 7 th 10 th
Days
Figure 8: Effect of C. laevigatus methanolic extract on body weight of animals. 32
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
33. Administration of C. laevigatus methanolic extract at doses 500 and 1000mg/kg did not
produce significant alteration of food and water consumption in treated groups.
18 Normal
16 CL-500mg/kg
Food consumption gms/cages (5 animals)
14 CL-750mg/kg
12
10
8
6
4
2
0
1 st 4 th 7 th 10 th
Days
Figure 9: Effect of C. laevigatus methanolic extract on food consumption of animals. 33
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
34. 9
Normal
8
Water consumption ml/cages(5animals)
CL- 500mg/kg
7
CL-750mg/kg
6
5
4
3
2
1
0
1 st 4 th 7 th 10 th
34
Days
Figure 10: Effect of C. laevigatus methanolic extract on water consumption of animals.
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
35. Administration of C. laevigatus methanolic extract at doses of 500 and
1000 mg/kg of body weight did not produce any change in the weight
of organs such as liver, kidney, spleen, heart and lungs.
Table 3: Effect of C. laevigatus methanolic extract on organ weight. Values are mean ± SD
of 5 animals/group and expressed as the organ weight/100 g of body weight.
Group Liver (g) Kidney (g) Spleen (g) Heart (g) Lungs (g)
Normal 1.425±0.47 0.442 ± 0.21 0.103 ± 0.018 0.131±0.03 0.257±0.052
C. laevigatus 1.42±0.19 0.415±0.036 0.097 ±0.016 0.145±0.021 0.289±.05
methanolic extract
(500 mg/kg)
C. laevigatus 1.54±0.19 0.415±0.036 0.097± 0.02 0.151±0.017 0.305±0.071
methanolic extract
(1000 mg/kg) 35
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
36. Administration of C. laevigatus methanolic extract at doses of 500 and did not produce any
change in hepatic parameters such as SGOT, SGPT, bilirubin, albumin & globulin. This
indicates that C. laevigatus methanolic extract at high concentration did not produce any
hepatic damage
Table 4: Effect of C. laevigatus methanolic extract on Liver Function test. Values are mean ± SD of
5 animals/group.
Group SGOT (U/L) SGPT (U/L) Bilirubin Total protein Albumin Globulin
(mg/dL) (g/dL) (g/dL) (g/dL)
Normal 154.2± 29.63 88.42±22.15 0.2±0.11 6.28±0.5 2.82±0.53 2.1±0.24
C. laevigatus 149.5± 50.53 82.9±19.4 0.2±0.88 7.48±1.2 3.54±0.19 2.5±0.34
methanolic extract
(500 mg/kg)
C. laevigatus 162.2± 42.43 76.2±27.83 0.17±0.13 8.34±0.98 3.23±0.65 3.2±0.29
methanolic extract
(1000 mg/kg)
36
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
37. Administration of C. laevigatus methanolic extract at doses of 500 and 1000 mg/kg of body
weight for 14 days did not produce any change in the renal function as the creatinine level
was similar to that of normal. This indicates that C. laevigatus methanolic extract did not
produce any toxicity to kidney and other renal tissues at the concentrations studied here.
Table 5: Effect of C. laevigatus methanolic extract on Renal Function test. Values are mean
± SD of 5 animals/group.
Group Creatinine (mg/dL)
Normal 0.53 ± 0.09
C. laevigatus methanolic extract (500 mg/kg) 0.48 ± 0.2
C. laevigatus methanolic extract (1000 0.52 ± 0.17
mg/kg)
37
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
38. Administration of C. laevigatus methanolic extract for 14 days, at doses of 500 and 1000
mg/kg did not produce any change in hematological parameters in the animals such as
total, WBC, RBC, platelet, haemoglobin as well as the differential count. This again
indicates that C. laevigatus methanolic extract high doses were found to be non toxic to
hematological system.
Table 6: Effect of C. laevigatus methanolic extract on hematological parameters. Values are
mean ± SD of 5 animals/group.
Group Hb (g/dL) WBC (mm3) RBC Platelet (105/cmm)
(106/cmm)
Normal 12.37±0.697 9170±149.88 7.86±0.6 6.48±1.84
C. laevigatus methanolic extract (500 13.18 ± 1.09 8450±528.98 6.89±0.81 5.89±2.19
mg/kg)
C. laevigatus methanolic extract 13.64±0.687 7445±527.89 7.01±0.98 6.68±1.15
(1000 mg/kg)
38
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
39. Table 7: Effect of C. laevigatus methanolic extract on hematological parameters - on
differential counts. Values are mean ± SD of 5 animals/group.
Group Lymphocyte Eosinophils Basophils Neutrophils Monocytes
(mm3) (mm3) (mm3) (mm3) (mm3)
Normal 6450.4±324.52 256±40.83 227±52.27 1264±70.5 225.4±64.78
C. laevigatus 5974.8±412.25 196.2±40.31 204±44.2 1064±126.5 210±72.1
methanolic extract
(500 mg/kg)
C. laevigatus 5780.6±246.85 224±74.81 196±33.8 1664±39.1 273±19.4
methanolic extract
(1000 mg/kg)
39
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
40. 5 Anti-inflammatory activity
5.1 Carrageenan induced acute inflammatory model
The sub-plantar injection of carrageenan into the mice hind paw elicited an
inflammation that was maximal at 3rd hour. The inflammatory response was significantly
reduced by the C. laevigatus methanol extract at doses of 500 and 750 mg/kg body weight
when compared to control with the percentage inhibition of 46.29 (p<0.01) and 50.74%
(p<0.001) respectively, 3rd hour following carrageenan injection.
Table.8: Effect of C. laevigatus methanol extract in carrageenan induced paw oedema. Values
are Mean ± SD; n=6 in each group (***) p<0.001, (**) p<0.01 as compared to control.
Groups Initial paw Paw thickness on 3rd Increase in paw % of
thickness hour thickness inhibition
Control 0.2185±0.0110 0.3647±0.0519 0.1462 ___
Diclofenac 0.2010±0.0189 0.2665±0.0192*** 0.0655 55.19
C. laevigatus methanolic 0.2082±0.0215 0.2867±0.0149** 0.0785 46.29
extract (500 mg/kg)
C. laevigatus methanolic 0.2035±0.0168 0.2755±0.0268*** 0.0720 50.74
extract (750 mg/kg) 40
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
41. 5.2. Formalin induced chronic inflammatory model
In mice treated with C. laevigatus methanol extract showed reduction in paw oedema
induced by sub-plantar injection of formalin with percentage inhibition 25.78 (p<0.01) and
33.43% (p<0.001) respectively at the doses 500 and 750 mg/kg body weight, on the 3th
day.
Table 9: Effect of C. laevigatus methanol extract in formalin induced paw edema. Values are
Mean ± SD; n=6 in each group (***) p<0.001, (**) p<0.01 as compared to control.
Groups Initial paw Paw thickness on 3rd Increase in paw % of inhibition
thickness day thickness
Control 0.1936±0.0154 0.4000±0.0350 0.2064 ___
Diclofenac 0.1888±0.0184 0.3204±0.0144*** 0.1316 36.24
C. laevigatus 0.1898±0.0061 0.3430±0.0103** 0.1532 25.78
methanolic extract
(500 mg/kg)
C. laevigatus 0.1938±0.0147 0.3312±0.0189*** 0.1374 33.43
methanolic extract
(750 mg/kg)
41
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
42. 6 Anti-tumour analysis
6.1 Effect of C. laevigatus methanol extract on solid tumour development
The animals injected with DLA cell lines alone showed marked increase in tumour volume
on the 30th day of inoculation in control group. The tumour volume in the mice treated with 500 and
750 mg/kg on the 30th day of inoculation decreased significantly by 58.35 and 62.02% respectively.
The tumour volume had decreased by 64.78% in cyclophosphamide (10 mg/kg) treated group.
0.40
Normal
0.35 Cyclophosphamide 10mg/kg
C. laevigatus 500 mg/kg
0.30
C. laevigatus 750 mg/kg
Tumor volume in cm3
0.25
0.20
0.15
0.10
0.05
0.00
0 3 6 9 12 15 18 21 24 27 30 33
Time intervels in Days
Figure 11: Effect of C. laevigatus methanol extract on solid tumour development. 42
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
43. 6.2 Effect of C. laevigatus methanol extract on ascites tumour development
The animals of the tumour control group inoculated with EAC cells survived for
a period 16±1.095 days. The C. laevigatus methanol extract at the 500 and 750 mg/kg
body weight was found to be inhibiting the proliferation of EAC with the percentage
increase in life span by 60.44 and 84.38%. In cyclophosmide treated mice (10 mg/kg), the
percentage increase in life span was found to be 93.75%.
Table 10: Effect of C. laevigatus methanol extract on average life span of ascites tumour
bearing mice. Values are Mean ± SD; n=6 in each group (***) p<0.001, (**) p<0.01 as
compared to control.
Treatment Mean survival days % increase in life span
Control (Normal Saline) 16±1.095 ___
Cyclophosphamide 10 31±2.28*** 93.75
mg/kg
C. laevigatus 500 mg/kg 25.67±6.623** 60.44
C. laevigatus 750 mg/kg 29.50±5.505*** 84.38 43
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
44. DISCUSSION
•The plant C. laevigatus spread along India
to China have been in use as traditional anti-
inflammatory medicine it has never been
studied for its pharmacological activity
except for the diterpenoids which is found in
most of the Crotons and the less abundant
neocrotocembraneic acid.
44
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
45. •The extract showed cytotoxicity towards the DLA, EAC and
Jurkat cells with an IC50 value of 37, 52 and 87
µg/ml, respectively.
•The extract on anti-oxidant screening showed significant
activity with an IC50 value of 130, 110 and 890 µg/ml with
DPPH, superoxide and hydroxyl radical assay, respectively.
•The acute toxicity studies showed the safety profile of the
extract. The extract at doses of 500 and 1000 mg/kg did not
produce any mortality in mice; it also showed that the
haematological and non-haematological parameters were
similar to that of normal.
45
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
46. •It has been already reported that diterpenoids and
laevigatbenzoate isolated from C. laevigatus has shown
modest cytotoxicity towards HeLA cell lines (Zou et al., 2010).
•The cytotoxicity exhibited towards the DLA, EAC and Jurkat
cell lines in the present study may be due to the presence of
the same constituents.
•The polyphenols present in the C. laevigatus may responsible
the anti-oxidant property.
46
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
47. •The inflammation in the carageenan induced
inflammatory model has significantly reduced
in paw thickness on the 3rd hour which is
comparable to the standard diclofenac.
•The formalin induced chronic inflammation
has considerably reduced on the 3rd day
which is comparable to standard dicofenac.
47
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
48. •The anti-inflammatory activity may be due to the
present of the β-sitosterol which is a cholesterol
analogue (Zou et al., 2010).
•The steroids are reported to inhibit the
phospholipase A2 which prevent the synthesis of
inflammatory mediators.
•The lactonecembranoids belonging to the
neocrotcembraneic acid isolated from the C.
laevigatus is known to posses inhibitory action on
cAMP phosphodiesterase may also support the anti-
tumour activity.
48
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
49. •The lactonecembranoids which belongs to
the neocrotocembraneic acid previously
isolated from the stem bark of Croton
oblongifolius showed considerable inhibition
of cAMP Phosphodiesterase (Sophon et
al., 2002) which is also isolated from C.
laevigatus (Zou et al., 2010) may be
responsible for its significant anti-
inflammatory activity.
49
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
50. •The anti-tumour analysis was performed based on
the cytotoxicity activity observed in various
transformed cells.
•The anti-tumour studies showed that the extract
posses significant activity. It has increased the
percentage life span by 60.44 and 84.38% in 500
and 750 mg/kg extract treated mice.
•It has also reduced the tumour volume by 58.35
and 62.02% in 500 and 750 mg/kg extract treated
mice on the 30th day of DLA inoculation in mice.
50
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
51. •The acute toxicity studies have proved the safety
profile of C. laevigatus and all the parameters
assessed was similar to that of the untreated
normal. It also signifies the importance of the plant
C. laevigatus as potent anticancer drug.
•The anti-oxidant activity along with its anti-
inflammatory effect has established its safeness to
be used for further studies.
51
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
52. CONCLUSION
•A considerable increase in life span in ascites tumour
bearing mice and percentage decrease in the tumour
volume in the solid tumour model in a dose dependent
manner when compared with the standard drug is
evident for the anti-tumour activity of the plant C.
laevigatus Vahl.
•The toxicity study result showed very little changes
when compared with normal result along with the anti-
oxidant and anti-inflammatory activity has established
the bio-safety profile of the plant, supporting its use in
the future studies to determine its hidden potentials. 52
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
53. •The result of the anit-oxidant, anti-inflammatory
assays performed also supports the anti-tumour
activity.
•Further research has to be performed to evaluate
their pharmacological profile and to check the
efficiency of the plant C. laevigatus in controlling
various types of diseases.
53
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
54. BIBLIOGRAPHY
• Abo KA, Ogunleye VO and Ashidi JS (1999). Antimicrobial potential of Spondias
mombin, Croton zambesicus and Zygotritonia crocea. Phytotherapy
Research, 13(6): 494-497.
• Amrithpal S (2007). Herbal Medicine-Dream unresolved. Pharmacognosy reviews
1(2), 375-377.
• Baderschneider B and Winterhalter P (2001). Journal of Agriculture and Food
Chemistry 49: 2788.
• Bisset NG (1991). Journal of Ethnopharmacolology, 32:71.
• Block S, Stevigny C, Llabres G, deHoffman E, Adjakide V, DePauw-Gillet M and
Quertin-Leclercq J (2002). Ent-Trachyloban-3β-ol, a new cytotoxic diterpene from
Croton zambesicus. Plantae Medica, 68:647-648.
• Choi EM and Hwang JK (2005). Effect of some medicinal plants on plasma anti-
oxidant system and lipid levels in rats. Phytother Res 19:382-386.
• Di Rosa M, Giroud JP and Willoughby DA (1971). Studies of the mediators of the
acute inflammatory response induced in rats in different sites by carrageenin and
turpentine. Journal of Patholgy 104, 15.
54
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
55. • Elizabeth K and Rao MNA 1990. Oxygen radical scavenging activity of curcumin.
International Journal of Pharmaceutics 58, 237-240.
• Guo AZ, Hong WZ, Haji AA, Jun SY, Chao ZP and Zhong MZ (2011). Laevigatbenzoate
from Croton laevigatus Vahl. Journal of Natural Medicine, 65:391-394.
• Halliwell B and Gutteridge JMC (1995). Protection of oxygen radicals in Biological
systems and free radicals in biology and medicine.
• Ialenti A, Ianaro A, Moncada S and Di Rosa M (1995). Modulation of acute
inflammation by endogenous nitric oxide. European Journal of Pharmacology 211, 177-
184.
• Logani MK and Davis RE (1979). Lipid peroxidation in biologic effects and anti-
oxidants. A Rev Lipids 15:485-93.
• Mitchell RN and Cotran RS (2000). Robinsons Basic Pathology. 7th edition, 33-42.
• Newman DJ et al. (1997). Journal of Natural Products, 60: 52.
• Okokon JE and Nwafor PA (2009a). Antiplasmodial activity of root extract and fractions
of Croton zambesicus. Journal of Ethnopharmacology, 121: 74-78.
• Osbourn AE, Qi X, Townsend B and Qin B (2003). Dissecting plant secondary
metabolism - constitutive chemical defences in cereals. New Phytol., 159, 101-108.
• Samir M and Amrit PS (2007). A review of pharmacology of phytochemicals from
indian medicinal plants. The Internet Journal of Alternative Medicine 5, 1. 55
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
56. •Santos PML, Schripsema J, Kuster, RM (2005). glycosylated flavonoids from Croton
campestris St. Hill.(Euphorbiaceae). Rev. Bras. Farmacog., 15:321-325.
•Sneader W (2005). Drug Discovery: a History.
•Szentmihalyi K, Taba G, Lado C, Fodor J, Then M, Szoke E, (2005). Medicinal plant
teas recommended as nutritional source for element supplementation. Acta Aliment
34:161-167.
•Website: Phytochemicals for cancer prevention.
•Wong C, Li H, Cheng K and Chen F (2006). A systematic survey of anti-oxidant
activity of 30 Chinese medicinal plants using the ferric reducing anti-oxidant power
assay. Food Chemistry 97, 705–711.
•Zhang L and Demain AL (2005). Natural products drug discovery and therapeutic
medicine. (ed) Springer.
•Zheng W and Wang SY (2001). Anti-oxidant activity and phenolic compounds in
selected herbs. J. Agric. Food Chem, 49:5165-5170.
•Zou GA, Aisa HA, Zhang HW, Yang JS and Zou ZM (2012). Chemical composition of
Croton laevigatus. Chemistry of Natural Compounds 47, 6.
•Zou GA, Ding G, Su ZH, Yang JS, Zhang HW, Peng CZ, Aisa HA and Zou ZM
(2010). Lactonecembranoids from Croton laevigatus. Journal of Natural Products 73,
792-795. 56
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
57. 57
RVS COLLEGE OF PHARMACEUTICAL SCIENCES, SULUR, COIMBATORE Friday, March 15, 2013
Editor's Notes
My project title is evaluation of anti-oxidant and anti-tumour activities of croton laevigatusvahl.
The natures greatest gift to mankind are the medicinal plants. These compounds protect the plants from infections microorganisms, pests, various climatic stress conditions and other hazards in the environment.
AIM & OBJECTIVEThe present investigation is focused on detecting therapeutics from the plant Croton laevigatusVahl.
PLAN OF WORK The selected plant C. laevigatusVahl. will be collected and authenticated. The leaves of the plant will be made free from dust particles, dried under shade and powdered coarsely. The powder will be extracted using methanol by overnight stirring (maceration). The extract will be subjected to preliminary phytochemical screening to determine the phytoconstituents present. Then in-vitro studies i.e. cytotoxicity and anti-oxidant studies will be carried out to decide whether to continue the study with the extract. If the methanol extract shows promising activity, the screening will be proceeded further for in-vivo anti-inflammatory and anti-tumour activity. The schematic representation of the plan work is shown in the Fig.1.
Distribution: India to China. In Kerala the plant is seen in Kasaragode, Malappuram, Thrissur, Eranakulam and Alappuzha.Habitat: Scrub forests; also in plains.Description: Usually shrubs or trees, up to 15 m tall; indumentum with dense, appressedstellate hairs; branches glabrescent, older branches silvery gray.Stems and leaves: Leaves clustered at stem apex; stipules subulate, 2-3 mm, caducous; petiole 1-5 cm; leaf blade elliptic or oblong-elliptic to oblanceolate, 7-25 × 3-9 cm, papery, abaxially with sparse stellate hairs, glaucous-gray when dried, adaxially glabrescent, base attenuate, base of midrib with abaxial sessile semiorbicular glands, margins subentire, usually with glands, bilateral apex acuminate.Flowers: Inflorescences terminally clustered, 10-30 cm, persistently hairy. Male flowers: sepals ca. 2 mm, densely and appressedstellate-hairy; petals oblong, ca. 2 mm, margins woolly; stamens 12-15. Female flowers: sepals as in male; petals small; ovary with densely appressedstellate hairs. Capsules obovoid or trigonous, ca. 10×8 mm, densely hairy. Flowering during October to December.Fruits: fruiting during December to March.Specimen sampled: leaf.Authentication: The plants were authenticated by Dr. P. Sujanapal, Taxonomist, Kerala Forest Research Institute (KFRI), Peechi.
The sample was dried in shade and powdered using mixer grinder.
The powder was extracted with HPLC grademethanol by maceration. The extract was filtered through Whatman #1 filter paper and the filtrate was evaporated to dryness, dissolved in Normal Saline (NS) and used for biological analysis.
Alkaloids, Carbohydrates, Proteins, Amino acids, Steroids, Glycosides, Saponnins, Phenolic Compounds and Tannins.A) Tests for Alkaloids: 1. Dragendorff’s Test: To the extract, add 1ml of Dragendorff’s reagent. An orange red colour precipitate indicates the presence of alkaloids.2. Wagner’s Test: To the extract, add 1ml of Wagner’s reagent. Reddish brown colour precipitate indicates the presence of alkaloids.3. Mayer’s Test: To the extract, add 1ml of Mayer’s reagent. A dull white colour precipitate indicates the presence of alkaloids.4. Hager’s Test: To the extract, add 3ml of Hager’s reagent. Yellow colour precipitate indicates the presence of alkaloids.B) Tests for Carbohydrates:1. Molish Test: To the extract, 1ml of α-naphthol solution was added and conc. Sulphuric acid was added along the sides of the test tube. Purple or Reddish violet colour at the junction between the two liquids indicates the presence of carbohydrates.2. Fehling Test: To the extract, equal quantities of Fehling’s solution A & B were added. Upon heating gently, a brick red precipitate indicates the presence of carbohydrates.3. Benedict’s Test: To 5ml of Benedict’s reagent, 8 drops of solution under the test was added and mixed well. Then it was boiled vigorously for 2 minutes and cooled. Red precipitate indicates the presence of carbohydrates.C) Tests for Proteins:1. Biuret Test: To the extract, 1ml of 40% sodium hydroxide and 2 drops of 1% copper sulphate solution was added. A violet colour indicates the presence of proteins.2. Xanthoprotic Test: To the extract, 1ml of conc. Nitric acid was added. When a white precipitate was formed, it is boiled and cooled. Then 20% of sodium hydroxide or ammonia was added. Orange colour indicates the presence of aromatic amino acids.3. Lead Acetate Test: To the extract, 1ml of lead acetate solution was added. A white precipitate indicates the presence of proteins.D) Test for Amino acids: 1. Ninhydrin Test: 2 drops of freshly prepared 0.2% ninhydrine reagent was added to the extract and heated. Development of blue colour indicates the presence of proteins, peptides or amino acids.E) Tests for Steroids: 1. LibbermannBurchard Test: The extract was dissolved in 2ml chloroform in dry test tube. 10 drops of acetic anhydride and 2 drops of conc. Sulphuric acid were added. The solution becomes red, and then blue and finally bluish green in colour indicates the presence of steroids.2. Salkowaski Test: The extract was dissolved in chloroform and equal volume of Sulphuric acid was added to it. Bluish red to cherry red colour was observed in chloroform layer; whereas acid layer assumes marked green fluorescence indicates the presence of steroids.F) Test for Glycosides:1. Keller-killani Test: Test sample was dissolved in acetic acid containing trace of ferric chloride and transferred to the surface of conc. Sulphuric acid. At the junction, reddish brown colour was formed, which gradually becomes blue indicates the presence of cardiac glycosides.G) Test for Saponnins:1. Foam Test: About 1ml of extract is diluted separately with distilled water to 20ml and shaken in a graduated cylinder for 15 minutes. A 1cm layer of foam indicates the presence of saponnins.H) Test for Phenolic Compounds and Tannins: Small quantities of alcoholic and aqueous extracts in water were tested for the presence of phenolic compounds and tannins with dilute ferric chloride solution (5%), 1% solution of gelatine containing 10% sodium chloride, 10% lead acetate and bromine solutions.
4.1 In vitro cytotoxicity assay by trypan blue dye exclusion methodPrinciple Viable cells exclude the dye while non-viable cells take up the dye and will appear in blue colour under magnification by a microscope.Materials requiredDaltons lymphoma ascites, Jurkat and Ehrlich ascites carcinoma cells maintained in Amala Cancer Research centre were used for the assay, Phosphate Buffer Saline (PBS pH 7.4), trypan blue, and haemocytometer.Procedure Short-term cytotoxicity activity of the C. laevigatus methanol extract was assayed by determining the percentage viability of DLA, EAC and Jurkat cells using the trypan blue dye exclusion technique (Moldeuset al., 1978). DLA and EAC cells were cultured in the peritoneal cavity of healthy albino mice weighing between 25 to 30g by injecting a suspension of cells (1x 106 cells/ml), intraperitoneally. The DLA and EAC cells were aspirated aseptically from the peritoneal cavity of the mice on day 15 and Jurkat cells were collected from the in vitro culture bottles (RPMI1640 medium with 10% Fetal Bovine Serum (FBS) and supplemented with antibiotics penicillin and streptomycin) and washed with PBS (pH 7.4) and centrifuged for 15 min at 1,500 rpm in a centrifuge. The pellet was re-suspended with PBS and the process was repeated three times. Finally, the cells were suspended in a known quantity of PBS and the cell count was adjusted to 1×106 cells/ml. The tumour cells (1x106 cells/ml) were incubated at 37°C for 3 hrs with different concentrations of drug (25-150 µg). After incubation, 0.1 ml of trypan blue was added. The cytotoxicity activity was determined by counting the number of dead cells to that of live cells using haemocytometer and substituting in the equation: % of cytotoxicity = Number of dead cells x 100 Number of total cells
DPPH-1,1-diphenyl-2-picrylhydrazyl.5.1 DPPH radical scavenging assayPrinciple In its radical form, DPPH has an absorption band at 515 nm, which disappear on its reduction. Scavenging of DPPH radical by anti-oxidant compounds will decrease the colour intensity, which can be compared with the control to get the percent inhibition.Reagents Methanol and freshly prepared DPPH stored in brown bottleProcedure Different concentrations of extract of C. laevigatus were added to 0.375 ml of freshly prepared DPPH solution in methanol. The volume was made up to 2 ml with methanol. After 20 minutes, the absorbance was measured at 515 nm. The percentage inhibition was calculated and concentration needed for 50% inhibition was found out.% of inhibition = OD of control - OD of test X 100 OD of control5.2 Superoxide radical scavenging activityPrinciple The superoxide scavenging was determined by the Nitro Blue Tetrazolium (NBT) reduction method, which depends on light induced super oxide radical generation by riboflavin. The super oxide radical will reduce the NBT to a blue colouredformazan complex, which is measurable at 560 nm.Reagents Phosphate buffer (0.06M, pH 7.8), EDTA (0.1M) containing 1.5 mg of sodium cyanide per 100 ml, riboflavin (0.12 mM) stored cold in a dark bottle and NBT (1.5 mM) stored cold. Procedure The scavenging activityof extracts on superoxide anion radicals was determined by light induced superoxide generation with riboflavin and subsequent reduction of nitro blue tetrazolium (NBT) (McCord and Fridovich, 1969). Different concentrations of extracts ranging from 100 to 1000 μg/ml were added to the reaction mixture containing 3 μg NaCN in 0.1 M EDTA; 0.12 mM riboflavin and 0.6 M phosphate buffer (pH 7.8) in a final volume of 3 ml. The tubes containing the reaction mixture were continuously illuminated with incandescent lamp for 15 min. The Optical Density (OD) measurements were taken at 530 nm before and after illumination. The effect of test material to inhibit superoxide generation was evaluated by comparing the OD of control and treated samples.% of inhibition = OD of control - OD of test X 100 OD of control5.3 Hydroxyl radical scavenging activityPrinciple Hydroxyl radical scavenging was measured by studying the competition between deoxyribose and the test compounds for hydroxyl radicals generated from the Fe3+/ascorbate/EDTA/H2O2 system (Fenton reaction). The hydroxyl radical attacks epoxy ribose, which eventually results in Thiobarbituric Acid Reacting Substances (TBARS) formation, which is estimated using a spectrophotometer at 530 nm.ReagentsHydroxyl buffer (pH 7.4), H2O2 (1 mM) prepared freshly and stored in a brown bottle, EDTA (0.1 mM), FeCl3 (0.1 mM) prepared freshly and stored in brown bottle, Ascorbic acid (0.1 mM) freshly prepared, deoxy ribose (2.8 mM). Procedure The scavenging activity of extracts on the hydroxyl radical (OH-) was measured by the Thiobarbituric Acid Reacting Substances (TBARS) method. The scavenging activity was measured by studying the competition between scavenging and test compounds for hydroxyl radical generated by the Fe3+/ascorbate/H2O2 system (Fenton reaction). The hydroxyl radical attacks deoxyribose eventually resulting in the formation of Thiobarbituric Acid Reacting Substances (Elizabath and Rao, 1990). The reaction system contained deoxyribose (2.8 mM), FeCl3 (0.1 mM), KH2PO4 KOH buffer (20 mM; pH 7.4) and from 100 to 1000 μg/ml of the test material in a final volume of 1 ml. The reaction mixture was incubated for 37o C for 1 hour. The scavenging activity of hydroxyl radicals was expressed as % of inhibition = OD of control – OD of test X 100 OD of control
DPPH-1,1-diphenyl-2-picrylhydrazyl.5.1 DPPH radical scavenging assayPrinciple In its radical form, DPPH has an absorption band at 515 nm, which disappear on its reduction. Scavenging of DPPH radical by anti-oxidant compounds will decrease the colour intensity, which can be compared with the control to get the percent inhibition.Reagents Methanol and freshly prepared DPPH stored in brown bottleProcedure Different concentrations of extract of C. laevigatus were added to 0.375 ml of freshly prepared DPPH solution in methanol. The volume was made up to 2 ml with methanol. After 20 minutes, the absorbance was measured at 515 nm. The percentage inhibition was calculated and concentration needed for 50% inhibition was found out.% of inhibition = OD of control - OD of test X 100 OD of control5.2 Superoxide radical scavenging activityPrinciple The superoxide scavenging was determined by the Nitro Blue Tetrazolium (NBT) reduction method, which depends on light induced super oxide radical generation by riboflavin. The super oxide radical will reduce the NBT to a blue colouredformazan complex, which is measurable at 560 nm.Reagents Phosphate buffer (0.06M, pH 7.8), EDTA (0.1M) containing 1.5 mg of sodium cyanide per 100 ml, riboflavin (0.12 mM) stored cold in a dark bottle and NBT (1.5 mM) stored cold. Procedure The scavenging activityof extracts on superoxide anion radicals was determined by light induced superoxide generation with riboflavin and subsequent reduction of nitro blue tetrazolium (NBT) (McCord and Fridovich, 1969). Different concentrations of extracts ranging from 100 to 1000 μg/ml were added to the reaction mixture containing 3 μg NaCN in 0.1 M EDTA; 0.12 mM riboflavin and 0.6 M phosphate buffer (pH 7.8) in a final volume of 3 ml. The tubes containing the reaction mixture were continuously illuminated with incandescent lamp for 15 min. The Optical Density (OD) measurements were taken at 530 nm before and after illumination. The effect of test material to inhibit superoxide generation was evaluated by comparing the OD of control and treated samples.% of inhibition = OD of control - OD of test X 100 OD of control5.3 Hydroxyl radical scavenging activityPrinciple Hydroxyl radical scavenging was measured by studying the competition between deoxyribose and the test compounds for hydroxyl radicals generated from the Fe3+/ascorbate/EDTA/H2O2 system (Fenton reaction). The hydroxyl radical attacks epoxy ribose, which eventually results in Thiobarbituric Acid Reacting Substances (TBARS) formation, which is estimated using a spectrophotometer at 530 nm.ReagentsHydroxyl buffer (pH 7.4), H2O2 (1 mM) prepared freshly and stored in a brown bottle, EDTA (0.1 mM), FeCl3 (0.1 mM) prepared freshly and stored in brown bottle, Ascorbic acid (0.1 mM) freshly prepared, deoxy ribose (2.8 mM). Procedure The scavenging activity of extracts on the hydroxyl radical (OH-) was measured by the Thiobarbituric Acid Reacting Substances (TBARS) method. The scavenging activity was measured by studying the competition between scavenging and test compounds for hydroxyl radical generated by the Fe3+/ascorbate/H2O2 system (Fenton reaction). The hydroxyl radical attacks deoxyribose eventually resulting in the formation of Thiobarbituric Acid Reacting Substances (Elizabath and Rao, 1990). The reaction system contained deoxyribose (2.8 mM), FeCl3 (0.1 mM), KH2PO4 KOH buffer (20 mM; pH 7.4) and from 100 to 1000 μg/ml of the test material in a final volume of 1 ml. The reaction mixture was incubated for 37o C for 1 hour. The scavenging activity of hydroxyl radicals was expressed as % of inhibition = OD of control – OD of test X 100 OD of control
DPPH-1,1-diphenyl-2-picrylhydrazyl.5.1 DPPH radical scavenging assayPrinciple In its radical form, DPPH has an absorption band at 515 nm, which disappear on its reduction. Scavenging of DPPH radical by anti-oxidant compounds will decrease the colour intensity, which can be compared with the control to get the percent inhibition.Reagents Methanol and freshly prepared DPPH stored in brown bottleProcedure Different concentrations of extract of C. laevigatus were added to 0.375 ml of freshly prepared DPPH solution in methanol. The volume was made up to 2 ml with methanol. After 20 minutes, the absorbance was measured at 515 nm. The percentage inhibition was calculated and concentration needed for 50% inhibition was found out.% of inhibition = OD of control - OD of test X 100 OD of control5.2 Superoxide radical scavenging activityPrinciple The superoxide scavenging was determined by the Nitro Blue Tetrazolium (NBT) reduction method, which depends on light induced super oxide radical generation by riboflavin. The super oxide radical will reduce the NBT to a blue colouredformazan complex, which is measurable at 560 nm.Reagents Phosphate buffer (0.06M, pH 7.8), EDTA (0.1M) containing 1.5 mg of sodium cyanide per 100 ml, riboflavin (0.12 mM) stored cold in a dark bottle and NBT (1.5 mM) stored cold. Procedure The scavenging activityof extracts on superoxide anion radicals was determined by light induced superoxide generation with riboflavin and subsequent reduction of nitro blue tetrazolium (NBT) (McCord and Fridovich, 1969). Different concentrations of extracts ranging from 100 to 1000 μg/ml were added to the reaction mixture containing 3 μg NaCN in 0.1 M EDTA; 0.12 mM riboflavin and 0.6 M phosphate buffer (pH 7.8) in a final volume of 3 ml. The tubes containing the reaction mixture were continuously illuminated with incandescent lamp for 15 min. The Optical Density (OD) measurements were taken at 530 nm before and after illumination. The effect of test material to inhibit superoxide generation was evaluated by comparing the OD of control and treated samples.% of inhibition = OD of control - OD of test X 100 OD of control5.3 Hydroxyl radical scavenging activityPrinciple Hydroxyl radical scavenging was measured by studying the competition between deoxyribose and the test compounds for hydroxyl radicals generated from the Fe3+/ascorbate/EDTA/H2O2 system (Fenton reaction). The hydroxyl radical attacks epoxy ribose, which eventually results in Thiobarbituric Acid Reacting Substances (TBARS) formation, which is estimated using a spectrophotometer at 530 nm.ReagentsHydroxyl buffer (pH 7.4), H2O2 (1 mM) prepared freshly and stored in a brown bottle, EDTA (0.1 mM), FeCl3 (0.1 mM) prepared freshly and stored in brown bottle, Ascorbic acid (0.1 mM) freshly prepared, deoxy ribose (2.8 mM). Procedure The scavenging activity of extracts on the hydroxyl radical (OH-) was measured by the Thiobarbituric Acid Reacting Substances (TBARS) method. The scavenging activity was measured by studying the competition between scavenging and test compounds for hydroxyl radical generated by the Fe3+/ascorbate/H2O2 system (Fenton reaction). The hydroxyl radical attacks deoxyribose eventually resulting in the formation of Thiobarbituric Acid Reacting Substances (Elizabath and Rao, 1990). The reaction system contained deoxyribose (2.8 mM), FeCl3 (0.1 mM), KH2PO4 KOH buffer (20 mM; pH 7.4) and from 100 to 1000 μg/ml of the test material in a final volume of 1 ml. The reaction mixture was incubated for 37o C for 1 hour. The scavenging activity of hydroxyl radicals was expressed as % of inhibition = OD of control – OD of test X 100 OD of control
DPPH-1,1-diphenyl-2-picrylhydrazyl.5.1 DPPH radical scavenging assayPrinciple In its radical form, DPPH has an absorption band at 515 nm, which disappear on its reduction. Scavenging of DPPH radical by anti-oxidant compounds will decrease the colour intensity, which can be compared with the control to get the percent inhibition.Reagents Methanol and freshly prepared DPPH stored in brown bottleProcedure Different concentrations of extract of C. laevigatus were added to 0.375 ml of freshly prepared DPPH solution in methanol. The volume was made up to 2 ml with methanol. After 20 minutes, the absorbance was measured at 515 nm. The percentage inhibition was calculated and concentration needed for 50% inhibition was found out.% of inhibition = OD of control - OD of test X 100 OD of control5.2 Superoxide radical scavenging activityPrinciple The superoxide scavenging was determined by the Nitro Blue Tetrazolium (NBT) reduction method, which depends on light induced super oxide radical generation by riboflavin. The super oxide radical will reduce the NBT to a blue colouredformazan complex, which is measurable at 560 nm.Reagents Phosphate buffer (0.06M, pH 7.8), EDTA (0.1M) containing 1.5 mg of sodium cyanide per 100 ml, riboflavin (0.12 mM) stored cold in a dark bottle and NBT (1.5 mM) stored cold. Procedure The scavenging activityof extracts on superoxide anion radicals was determined by light induced superoxide generation with riboflavin and subsequent reduction of nitro blue tetrazolium (NBT) (McCord and Fridovich, 1969). Different concentrations of extracts ranging from 100 to 1000 μg/ml were added to the reaction mixture containing 3 μg NaCN in 0.1 M EDTA; 0.12 mM riboflavin and 0.6 M phosphate buffer (pH 7.8) in a final volume of 3 ml. The tubes containing the reaction mixture were continuously illuminated with incandescent lamp for 15 min. The Optical Density (OD) measurements were taken at 530 nm before and after illumination. The effect of test material to inhibit superoxide generation was evaluated by comparing the OD of control and treated samples.% of inhibition = OD of control - OD of test X 100 OD of control5.3 Hydroxyl radical scavenging activityPrinciple Hydroxyl radical scavenging was measured by studying the competition between deoxyribose and the test compounds for hydroxyl radicals generated from the Fe3+/ascorbate/EDTA/H2O2 system (Fenton reaction). The hydroxyl radical attacks epoxy ribose, which eventually results in Thiobarbituric Acid Reacting Substances (TBARS) formation, which is estimated using a spectrophotometer at 530 nm.ReagentsHydroxyl buffer (pH 7.4), H2O2 (1 mM) prepared freshly and stored in a brown bottle, EDTA (0.1 mM), FeCl3 (0.1 mM) prepared freshly and stored in brown bottle, Ascorbic acid (0.1 mM) freshly prepared, deoxy ribose (2.8 mM). Procedure The scavenging activity of extracts on the hydroxyl radical (OH-) was measured by the Thiobarbituric Acid Reacting Substances (TBARS) method. The scavenging activity was measured by studying the competition between scavenging and test compounds for hydroxyl radical generated by the Fe3+/ascorbate/H2O2 system (Fenton reaction). The hydroxyl radical attacks deoxyribose eventually resulting in the formation of Thiobarbituric Acid Reacting Substances (Elizabath and Rao, 1990). The reaction system contained deoxyribose (2.8 mM), FeCl3 (0.1 mM), KH2PO4 KOH buffer (20 mM; pH 7.4) and from 100 to 1000 μg/ml of the test material in a final volume of 1 ml. The reaction mixture was incubated for 37o C for 1 hour. The scavenging activity of hydroxyl radicals was expressed as % of inhibition = OD of control – OD of test X 100 OD of control
ProcedureMice were randomly divided into 3 groups. Each group consisted of 6 mice. The 1st group was kept as control and received 1 ml of vehicle normal saline every day. Group 2 and 3 received the drug at doses of 500 and 1000 mg/kg, respectively. Each dose was administered in such a way that all the animals received same volume (200 μl) of the drug. Drugs were administered orally in the prescribed dose (once daily) using oral needle and continued for 14 days. The animals were monitored, during this period for any type of clinical symptoms, mortality and any adverse reaction of the administered drug. Body weights were determined every 3 days. Animals were sacrificed on day 15th by ether anaesthesia; blood was collected by direct heart puncture method and taken in the EDTA and non-EDTA vials for assaying hematological parameters and serum biochemistry. All the organs were examined visibly for any type of abnormalities in the structure and selected organs like liver, kidney, heart, lungs and spleen were dissected out and washed thoroughly in ice-cold normal saline and weights were recorded.
7.1 Carrageenan induced acute inflammation The anti-inflammatory activity was evaluated by the carrageenan-induced paw edema test in the mice. Four groups of 6 animals each male Swiss albino mice (25-30 g, 6-8 weeks old) were injected with 0.02 ml of 1% suspension of carrageenan in normal saline, sub-plantar to the right hind paw. First group with carrageenan alone served as positive control. The group second was administered with diclofenac (10 mg/kg body weight) intraperitoneally as standard reference drug. The remaining group received extract at the doses of 500 and 750 mg/kg of body weight orally, for 5 consecutive days and on fifth day drug was administered 1 hour prior to induction of inflammation by carrageenan injection. Increase in paw thickness was measured using Vernier caliper before and after carrageenan injection and thereafter at first, second, third, fourth, fifth and twenty-fourth hours. The increase in thickness as a measure of inflammatory edema can be calculated by using the formula, Pt - Po where Po is initial thickness and Pt is thickness at time‘t’. 6.7.2 Formalin induced chronic inflammationThe inflammation was induced by using formalin in Swiss albino mice. All the animals were injected with 0.02 ml of 1% solution of formalin sub-plantar into right hind paw. Paw volume was measured 1hr prior and for 6 days after formalin administration using a Vernier caliper. The methanol extract of C. laevigatus leaves was given at doses of 500 and 750 mg/kg of body weight orally 1 hr prior to formalin injection. Diclofenac (10 mg/kg) was used as standard reference drug. The control group received equivalent volume of the vehicle. The increase in thickness as a measure of inflammatory oedema can be calculated by using the formula, Pt - Po where Po is initial thickness and Pt is thickness at time‘t’. Statistical analysis The values are presented as mean ± SD. Differences between group’s means were estimated using a one way analysis of variance followed by Tukey test, using Graph Pad In stat Software. The results were considered statistically significant when P<0.05.
8 Anti-tumour activity of methanol extract of leaves C. laevigatus.For assessing the anti-tumour activity, the Dalton’s lymphoma Ascites (DLA) and Ehrlich’s Ascites Carcinoma (EAC) cells induced solid and ascites tumour were used respectively.8.1 Solid tumour The dose of the extract of C. laevigatus was evaluated by a toxicity study and safe doses of 500 and 750 mg/kg body weight were determined. Animals were grouped in to four (6 animals/group). Group 1 served as untreated control, group 2 received cyclophosphamide (10 mg/kg), group 3 received C. laevigatus methanol extract (500 mg/kg) and group 4 received C. laevigatus methanol extract (750 mg/kg). The drug treatment was stared next day after the induction of tumour and continued for 10 days. The tumour development on animals in each group was determined by measuring the diameter of tumour growth in two perpendicular planes using Vernier calipers every third day for 4 week. The tumour volume was calculated using the formula V = 4/3 π r12 × r2 where r1 is the minor radius and r2 is the major radius.8.2 Ascites tumourEhrlich’s Ascites Carcinoma cells were aspirated from peritoneal cavity of the tumour bearing mice and 0.1 ml containing 1x106 cells was injected intraperitoneally into the Swiss Albino mice. Injecting EAC cells into the intra peritoneal cavity of mice produced ascites tumour. Animals were grouped in to four groups (6 animals/group). Group 1 served as untreated control, group 2 received cyclophosphamide (10 mg/kg), group 3 received C. laevigatus methanol extract (500 mg/kg) and group 4 received C. laevigatus methanol extract (750 mg/kg). The drug treatment has stared next day after the induction of tumour and continued for 10 days. The animals were observed for the development of ascites tumour and death due to tumour burden was recorded for 30 consecutive days. The life span of animals was calculated using the formula: % Increase in life span (ILS) = (T-C)/C×100, where T and C are mean survival of treated and control mice.
The effect of an anti-oxidant on DPPH radical scavenging was thought to be due to their hydrogen donating ability. DPPH, a stable free radical accepts an electron/hydrogen to become a stable diamagnetic molecule.
Superoxide anion derived from riboflavin reaction reduces NBT and the decrease of absorbance at 560 nm with anti-oxidants indicates the consumption of superoxide anion in the reaction mixture.
The degradation of deoxyribose to TBARS by hydroxyl radicals generated from Fe3+/ascorbate/EDTA/H2O2 system markedly decreased by C. laevigatus methanol extract.